834 related articles for article (PubMed ID: 27644617)
1. Association of Cytotoxic T-lymphocyte Antigen-4 Polymorphisms with Malignant Bone Tumor Risk: A Meta-analysis.
Zhang C; Hou WH; Ding XX; Wang X; Zhao H; Han XW; Wang WJ
Asian Pac J Cancer Prev; 2016; 17(8):3785-91. PubMed ID: 27644617
[TBL] [Abstract][Full Text] [Related]
2. Significant association between cytotoxic T lymphocyte antigen 4 +49G>A polymorphism and risk of malignant bone tumors.
Yu F; Miao J
Tumour Biol; 2013 Dec; 34(6):3371-5. PubMed ID: 23900675
[TBL] [Abstract][Full Text] [Related]
3. Associations between the cytotoxic T lymphocyte antigen 4 polymorphisms and risk of bone sarcomas.
Fan C; Zhao X; Xu Z
Tumour Biol; 2015 Jan; 36(1):227-31. PubMed ID: 25230787
[TBL] [Abstract][Full Text] [Related]
4. Polymorphisms in the cytotoxic T-lymphocyte antigen 4 gene and acute rejection risk in transplant recipients.
Zhu CL; Huang Q; Liu CH; Xie F
Mol Biol Rep; 2012 Sep; 39(9):8701-8. PubMed ID: 22711308
[TBL] [Abstract][Full Text] [Related]
5. [Association between cytotoxic T lymphocyte protein-4 polymorphisms and non-Hodgkin's lymphoma risk: a meta-analysis].
Yi B; Pei Y; Wang C; Jiang Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Aug; 32(8):1099-104. PubMed ID: 27412943
[TBL] [Abstract][Full Text] [Related]
6. Lack of association between cytotoxic T-lymphocyte antigen-4 -318C/T polymorphism and cancer risk: a meta-analysis of case-control studies.
Xia W; Shi R; Zheng WL; Ma WL
Technol Cancer Res Treat; 2013 Dec; 12(6):565-74. PubMed ID: 23745791
[TBL] [Abstract][Full Text] [Related]
7. Cytotoxic T-lymphocyte antigen-4 polymorphisms and susceptibility to osteosarcoma.
Liu Y; He Z; Feng D; Shi G; Gao R; Wu X; Song W; Yuan W
DNA Cell Biol; 2011 Dec; 30(12):1051-5. PubMed ID: 21612409
[TBL] [Abstract][Full Text] [Related]
8. Polymorphisms in the cytotoxic T-lymphocyte antigen 4 gene and cancer risk: a meta-analysis.
Zhang Y; Zhang J; Deng Y; Tian C; Li X; Huang J; Fan H
Cancer; 2011 Sep; 117(18):4312-24. PubMed ID: 21387262
[TBL] [Abstract][Full Text] [Related]
9. Meta-analysis of association between the +49A/G polymorphism of cytotoxic T-lymphocyte antigen-4 and thyroid associated ophthalmopathy.
Wang H; Zhu LS; Cheng JW; Cai JP; Li Y; Ma XY; Wei RL
Curr Eye Res; 2015; 40(12):1195-203. PubMed ID: 25615025
[TBL] [Abstract][Full Text] [Related]
10. Association between TP53 rs1042522 gene polymorphism and the risk of malignant bone tumors: a meta-analysis.
Huang X; Wu F; Zhang Z; Shao Z
Biosci Rep; 2019 Mar; 39(3):. PubMed ID: 30833364
[No Abstract] [Full Text] [Related]
11. Lack of association between CTLA-4 +49A/G and -318C/T polymorphisms and Behçet's disease risk: a meta-analysis.
Zhang YJ; Xu WD; Duan ZH; Liu SS; Pan HF; Ye DQ
Clin Exp Rheumatol; 2012; 30(3 Suppl 72):S46-50. PubMed ID: 23010350
[TBL] [Abstract][Full Text] [Related]
12. Association of cytotoxic T lymphocyte antigen-4 +49A/G polymorphism and cancer risk: An updated meta-analysis.
Gao X; Zhang S; Qiao X; Yao Y; Wang L; Dong D; Ma X; Wang T
Cancer Biomark; 2014; 14(4):287-94. PubMed ID: 24934372
[TBL] [Abstract][Full Text] [Related]
13. Cytotoxic T-lymphocyte antigen-4 genetic variants and risk of Ewing's sarcoma.
Feng D; Yang X; Li S; Liu T; Wu Z; Song Y; Wang J; Gao W; Huang Q; Huang W; Zheng W; Xiao J
Genet Test Mol Biomarkers; 2013 Jun; 17(6):458-63. PubMed ID: 23480667
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxic T-lymphocyte antigen-4 polymorphisms and susceptibility to Ewing's sarcoma.
Yang S; Wang C; Zhou Y; Sun G; Zhu D; Gao S
Genet Test Mol Biomarkers; 2012 Oct; 16(10):1236-40. PubMed ID: 22905924
[TBL] [Abstract][Full Text] [Related]
15. Association between cytotoxic T lymphocyte antigen-4 +49A/G, -1722T/C, and -1661A/G polymorphisms and cancer risk: a meta-analysis.
Geng R; Song F; Yang X; Sun P; Hu J; Zhu C; Zhu B; Fan W
Tumour Biol; 2014 Apr; 35(4):3627-39. PubMed ID: 24307627
[TBL] [Abstract][Full Text] [Related]
16. Lack of association between cytotoxic T-lymphocyte antigen-4+49A/G polymorphism and psoriasis and vitiligo: A meta-analysis of case-control studies.
Liang J; Zhang S; Luo Q; Li W; Tian X; Zhang F; Zhao T; Chen X; Zhang X
Gene; 2015 Sep; 568(2):196-202. PubMed ID: 26013045
[TBL] [Abstract][Full Text] [Related]
17. The association between CTLA-4 (+49 A/G) polymorphism and susceptibility to ankylosing spondylitis: a meta-analysis.
Wu J; Zhang L; Zhou Y
Int J Rheum Dis; 2016 Dec; 19(12):1237-1243. PubMed ID: 26176417
[TBL] [Abstract][Full Text] [Related]
18. Association between CTLA-4 genetic polymorphisms and susceptibility to osteosarcoma in Chinese Han population.
He J; Wang J; Wang D; Dai S; Yv T; Chen P; Ma R; Diao C; Lv G
Endocrine; 2014 Mar; 45(2):325-30. PubMed ID: 24078408
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxic T lymphocyte-associated antigen 4 rs231775 polymorphism and osteosarcoma.
Bilbao-Aldaiturriaga N; Patino-Garcia A; Martin-Guerrero I; Garcia-Orad A
Neoplasma; 2017; 64(2):299-304. PubMed ID: 28052683
[TBL] [Abstract][Full Text] [Related]
20. Association of CTLA-4 gene polymorphism with end-stage renal disease and renal allograft outcome.
Misra MK; Kapoor R; Pandey SK; Sharma RK; Agrawal S
J Interferon Cytokine Res; 2014 Mar; 34(3):148-61. PubMed ID: 24313821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
